Paragon 28, Inc. (NYSE: FNA) is a medical device company specializing in comprehensive solutions for foot and ankle surgery. Headquartered in Englewood, Colorado, the company develops, manufactures, and markets a diverse range of implants, instruments and digital platforms to support orthopedic surgeons. Since its founding in 2019, Paragon 28 has focused on delivering clinically driven products designed to address both routine and complex pathologies of the lower extremity.
The company’s product portfolio includes plating systems, intramedullary nails, compression staples, external fixation devices and patient-specific instrumentation. Paragon 28 also offers proprietary digital preoperative planning and post-operative monitoring tools that allow surgeons to tailor treatment plans, optimize implant selection and track patient outcomes. These integrated solutions are intended to enhance surgical precision, reduce operating room time and improve overall case efficiency.
With a global footprint, Paragon 28 serves hospitals, ambulatory surgery centers and physician practices across North America, Europe, Asia-Pacific and the Middle East. The company distributes its products through a combination of direct sales teams and regional distribution partners, investing in clinical education programs, cadaver labs and advisory boards to support surgeon training and adoption. Paragon 28’s international expansion has been driven by strategic partnerships and targeted product launches aligned with regional regulatory requirements.
Under the leadership of President and Chief Executive Officer Michael Macioci, Paragon 28 emphasizes a culture of innovation and collaboration. The company’s executive team and board of directors include experienced professionals from the orthopedic and medical technology sectors. Paragon 28 continues to pursue research and development initiatives aimed at refining surgical workflows and advancing next-generation implant technologies, while maintaining close engagement with key opinion leaders and academic institutions.
AI Generated. May Contain Errors.
